It is disappointing to see the drop. However, many of us longs understand that:
A). Benitec is still primarily an ASX listed company. As such, it is much more susceptible to manipulation until it lists on a major US exchange.
B). If TT-034 demonstrates efficacy by this summer and fall, the drop in share price will be a moot point.
However, it must be said that the best thing longs can do is not to speculate when SP will go up or down, but rather to sit and wait for news to confirm what we already believe to be true about ddRNAi. Manipulator son the ASX are taking advantage of the timing between dosing to drop the sp and scoop up more shares. I am not a day trader, nor can Benitec really be day traded nearly as easily in the U.S., even more so if you're a BTEBY holder.
It must be said though, as I mentioned before, that if the next two patients get the go ahead, then that likely means that it will be safe for the next cohort...which puts us into the beginnings of therapeutic levels.
:-)
News 
Market Data 
Discover 
